Focusing on timing selection and whole-course management of liver transplantation treatment for patients with acute-on-chronic liver failure.
10.3760/cma.j.cn501113-20230303-00092
- Author:
Tao HAN
1
;
Guo Wang LIU
1
Author Information
1. Department of Gastroenterology and Hepatology, Tianjin Union Medical Center Affiliated to Nankai University, Tianjin 300121, China.
- Publication Type:Journal Article
- Keywords:
Acute-on-chronic liver failure;
Artificial liver;
Liver transplantation;
Treatment
- MeSH:
Humans;
Liver Transplantation;
Acute-On-Chronic Liver Failure/complications*;
Survival Rate;
Liver Cirrhosis/complications*;
Prognosis
- From:
Chinese Journal of Hepatology
2023;31(6):561-563
- CountryChina
- Language:Chinese
-
Abstract:
Acute-on-chronic liver failure (ACLF) is a clinical syndrome of acute decompensation accompanied by organ failure that occurs on the basis of chronic liver disease and has a high short-term mortality rate. Currently, there are still differences in relation to the definition of ACLF; thus, baseline characteristics and dynamic changes are important bases for clinical decision-making in patients with liver transplantation and others. The basic strategies for treating ACLF currently include internal medicine treatment, artificial liver support systems, and liver transplantation. Multidisciplinary active collaborative management throughout the whole course is of great significance for further improving the survival rate in patients with ACLF.
